DYRK (dual-specificity tyrosine-regulated kinases) are an evolutionary conserved family of protein kinases. The DYRK family is formed by three subfamilies: the DYRK subfamily, the homeodomain-interacting kinases (HIPKs), and the pre-messenger RNA-processing protein 4 kinases (PRP4Ks). The DYRK subfamily contains five members in humans that are clustered into two classes based on their phylogenetic relationships: class I DYRKs, DYRK1A and DYRK1B (also known as Mirk from minibrain-related kinase) and class II DYRKs, DYRK2, DYRK3 (also known as REDK from regulatory erythroid kinase) and DYRK4. DYRKs are pleiotropic factors that phosphorylate a broad set of proteins involved in many different cellular processes. These include factors that have been associated with all the hallmarks of cancer, from genomic instability to increased proliferation and resistance, programmed cell death, or signaling pathways whose dysfunction is relevant to tumor onset and progression.[1]

[1] J Boni et al. The DYRK Family of Kinases in Cancer: Molecular Functions and Therapeutic Opportunities. Cancers (Basel). 2020 Jul 29;12(8):2106.

6 Item(s)

per page
Axon ID Name Description From price
2202 CK2 inhibitor 10 Potent and ATP-competitive inhibitor of CK2 €105.00
4056 DYRK1A inhibitor compound 11 Highly selective and ligand-efficient Dyrk1A inhibitor €150.00
2970 GSK626616 Potent, orally bioavailable inhibitor of DYRK3 €120.00
3627 Harmine Potent, selective and ATP-competitive DYRK1A inhibitor €50.00
3538 INDY Potent, selective and ATP-competitive inhibitor of Dyrk1A €110.00
3540 ProINDY Prodrug of INDY; Dyrk1A inhibitor €110.00

6 Item(s)

per page
Please wait...